Farhad Eisvand

772 total citations
26 papers, 602 citations indexed

About

Farhad Eisvand is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Farhad Eisvand has authored 26 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in Farhad Eisvand's work include Synthesis and biological activity (5 papers), Lipid Membrane Structure and Behavior (4 papers) and Advancements in Transdermal Drug Delivery (3 papers). Farhad Eisvand is often cited by papers focused on Synthesis and biological activity (5 papers), Lipid Membrane Structure and Behavior (4 papers) and Advancements in Transdermal Drug Delivery (3 papers). Farhad Eisvand collaborates with scholars based in Iran, United Kingdom and United States. Farhad Eisvand's co-authors include Farzin Hadizadeh, Bibi Marjan Razavi, Razieh Ghodsi, Salimeh Mirzaei, Fatemeh Mosaffa, Hossein Hosseinzadeh, Mahboobeh Ghasemzadeh Rahbardar, Maryam Rameshrad, Ali Ghasemi and Jamshid Tabeshpour and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and Life Sciences.

In The Last Decade

Farhad Eisvand

26 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farhad Eisvand Iran 13 211 190 76 70 54 26 602
Subham Das India 14 170 0.8× 165 0.9× 59 0.8× 32 0.5× 45 0.8× 42 563
Fernando Durães Portugal 10 176 0.8× 195 1.0× 144 1.9× 25 0.4× 60 1.1× 23 555
Asser I. Ghoneim Egypt 14 71 0.3× 183 1.0× 92 1.2× 60 0.9× 67 1.2× 33 606
Tarique Mahmood India 14 62 0.3× 196 1.0× 60 0.8× 56 0.8× 69 1.3× 93 677
Neelaveni Thangavel Saudi Arabia 13 90 0.4× 206 1.1× 51 0.7× 29 0.4× 64 1.2× 31 546
Xuehua Zheng China 18 112 0.5× 329 1.7× 92 1.2× 75 1.1× 33 0.6× 51 864
Chatchawan Changtam Thailand 16 194 0.9× 357 1.9× 120 1.6× 34 0.5× 46 0.9× 27 858
Luiz Antônio Soares Romeiro Brazil 15 174 0.8× 197 1.0× 223 2.9× 134 1.9× 67 1.2× 43 653
Lan Yang China 12 81 0.4× 222 1.2× 55 0.7× 71 1.0× 96 1.8× 52 531
Jun Fu China 18 146 0.7× 416 2.2× 71 0.9× 85 1.2× 61 1.1× 42 845

Countries citing papers authored by Farhad Eisvand

Since Specialization
Citations

This map shows the geographic impact of Farhad Eisvand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhad Eisvand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhad Eisvand more than expected).

Fields of papers citing papers by Farhad Eisvand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farhad Eisvand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhad Eisvand. The network helps show where Farhad Eisvand may publish in the future.

Co-authorship network of co-authors of Farhad Eisvand

This figure shows the co-authorship network connecting the top 25 collaborators of Farhad Eisvand. A scholar is included among the top collaborators of Farhad Eisvand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farhad Eisvand. Farhad Eisvand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khodaverdi, Elham, et al.. (2024). Preparation and characterization of injectable in-situ forming gel based on lipid liquid crystal for one month delivery of aripiprazole: In-vitro and in-vivo evaluations in rats. Journal of Drug Delivery Science and Technology. 96. 105640–105640. 2 indexed citations
2.
3.
Rahbardar, Mahboobeh Ghasemzadeh, et al.. (2024). Carnosic acid mitigates doxorubicin-induced cardiac toxicity: Evidence from animal and cell model investigations.. SHILAP Revista de lepidopterología. 27(4). 425–438. 7 indexed citations
4.
Eisvand, Farhad, et al.. (2023). Evaluating the effect of alpha-mangostin on neural toxicity induced by acrylamide in rats. Environmental Science and Pollution Research. 30(42). 95789–95800. 9 indexed citations
5.
Maleki, Mahdi Faal, Farhad Eisvand, Mohammad Mashreghi, et al.. (2023). Design, synthesis and biological evaluation of novel imidazole-based benzamide and hydroxamic acid derivatives as potent histone deacetylase inhibitors and anticancer agents. Journal of Molecular Structure. 1297. 136951–136951. 16 indexed citations
6.
Khodaverdi, Elham, et al.. (2022). Lipid-liquid crystals for 2 months controlled risperidone release: In-vitro evaluation and pharmacokinetics in rabbits. International Journal of Pharmaceutics. 618. 121649–121649. 11 indexed citations
7.
Khodaverdi, Elham, et al.. (2022). In-vitro and in-vivo evaluation of sustained-release buprenorphine using in-situ forming lipid-liquid crystal gels. Life Sciences. 314. 121324–121324. 5 indexed citations
8.
Khodaverdi, Elham, Mahdi Faal Maleki, Farhad Eisvand, et al.. (2022). A sustain-release lipid-liquid crystal containing risperidone based on glycerol monooleate, glycerol dioleate, and glycerol trioleate: In-vitro evaluation and pharmacokinetics in rabbits. Journal of Drug Delivery Science and Technology. 70. 103257–103257. 8 indexed citations
9.
Rahbardar, Mahboobeh Ghasemzadeh, et al.. (2021). In Vivo and In Vitro Protective Effects of Rosmarinic Acid against Doxorubicin-Induced Cardiotoxicity. Nutrition and Cancer. 74(2). 747–760. 42 indexed citations
10.
Eisvand, Farhad, Mohsen Imenshahidi, Mahboobeh Ghasemzadeh Rahbardar, et al.. (2021). Cardioprotective effects of alpha‐mangostin on doxorubicin‐induced cardiotoxicity in rats. Phytotherapy Research. 36(1). 506–524. 41 indexed citations
11.
Maleki, Mahdi Faal, Hamid Nadri, Najmeh Edraki, et al.. (2021). Design and synthesis of new carbamates as inhibitors for fatty acid amide hydrolase and cholinesterases: Molecular dynamic, in vitro and in vivo studies. Bioorganic Chemistry. 109. 104684–104684. 23 indexed citations
12.
13.
Kamali, Hossein, et al.. (2021). Comparison of lipid liquid crystal formulation and Vivitrol® for sustained release of Naltrexone: In vitro evaluation and pharmacokinetics in rats. International Journal of Pharmaceutics. 611. 121275–121275. 20 indexed citations
14.
Eisvand, Farhad, Amir Tajbakhsh, Véronique Seidel, et al.. (2021). Quercetin and its role in modulating endoplasmic reticulum stress: A review. Phytotherapy Research. 36(1). 73–84. 35 indexed citations
15.
Rahbardar, Mahboobeh Ghasemzadeh, et al.. (2020). Effect of carnosic acid on acrylamide induced neurotoxicity: in vivo and in vitro experiments. Drug and Chemical Toxicology. 45(4). 1528–1535. 30 indexed citations
16.
Eisvand, Farhad, Bibi Marjan Razavi, & Hossein Hosseinzadeh. (2020). The effects of Ginkgo biloba on metabolic syndrome: A review. Phytotherapy Research. 34(8). 1798–1811. 79 indexed citations
17.
Nejabat, Mojgan, Farhad Eisvand, Fatemeh Soltani, et al.. (2020). Combination therapy using Smac peptide and doxorubicin-encapsulated MUC 1-targeted polymeric nanoparticles to sensitize cancer cells to chemotherapy: An in vitro and in vivo study. International Journal of Pharmaceutics. 587. 119650–119650. 24 indexed citations
18.
Mirzaei, Salimeh, Farhad Eisvand, Farzin Hadizadeh, et al.. (2020). Design, synthesis and biological evaluation of novel 5,6,7-trimethoxy-N-aryl-2-styrylquinolin-4-amines as potential anticancer agents and tubulin polymerization inhibitors. Bioorganic Chemistry. 98. 103711–103711. 81 indexed citations
20.
Tabeshpour, Jamshid, et al.. (2019). Effects of curcumin on ion channels and pumps: A review. IUBMB Life. 71(7). 812–820. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026